CDER New August 3, 2018

August 2, 2018

• Drug Trials Snapshots: TIBSOVO
• FDA Drug Shortages
  • Atorvastatin Calcium Tablets (New - Discontinuation)
  • Atropine Sulfate Injection (Updated - Currently in Shortage)
  • Bumetanide Injection, USP (Updated - Currently in Shortage)
  • Diltiazem Hydrochloride (Updated - Currently in Shortage)
  • Fentanyl Citrate (Sublimaze) Injection (Updated - Currently in Shortage)
  • Hydromorphone Hydrochloride Injection, USP (Updated - Currently in Shortage)
  • Isocarboxazid Tablets (Updated - Currently in Shortage)
  • Ketamine Injection (Updated - Currently in Shortage)
  • Ketorolac Tromethamine Injection (Updated - Currently in Shortage)
  • Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
  • Morphine Sulfate Injection, USP (Updated - Currently in Shortage)
  • Ondansetron Hydrochloride Injection (Updated - Currently in Shortage)
  • Pantoprazole (Protonix) Powder for Injection (Currently in Shortage)
  • Phenytoin Sodium Injection, USP (Updated - Currently in Shortage)
  • Progesterone Injection, USP (Updated - Currently in Shortage)
  • Promethazine (Phenergan) Injection (Updated - Currently in Shortage)
  • Sodium Chloride Injection USP, 0.9% Vials (New - Currently in Shortage)